Do prothrombotic factors influence clinical phenotype of severe haemophilia? - A review of the literature

被引:60
作者
van Dijk, K
van der Bom, JG
Fischer, K
Grobbee, DE
van den Berg, HM
机构
[1] UMCU, Van Creveldklin, Dutch Natl Hemophilia Treatment Ctr, NL-3508 GA Utrecht, Netherlands
[2] UMC, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] UMC, Dept Clin Epidemiol, Leiden, Netherlands
[4] UMC, Wilhelmina Childrens Hosp, Utrecht, Netherlands
关键词
severe haemophilia; phenotype; prothrombotic factors;
D O I
10.1160/TH04-02-0112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is considerable variability in bleeding patterns of severe haemophilia (< 1% factor VIII). Knowledge of the contribution of thrombophilic factors in these patterns may improve individually tailored treatment strategies. We reviewed the literature regarding the relation between prothrombotic factors and clinical phenotype of severe haemophilia. Medline and EMBASE were searched for relevant articles. 9369 articles published between 1963 and September 2003 were screened and seven relevant papers were retrieved. Each of these reported on a different combination of thrombophilic factors. Presence of the factor V Leiden mutation appears to decrease the severity of severe haemophilia most consistently. Findings on other thrombophilic factors were inconclusive. There is a clear need for additional research on potential determinants of phenotypes of severe haemophilia before such knowledge can be translated into individual care for severe haemophilia patients with confidence.
引用
收藏
页码:305 / 310
页数:6
相关论文
共 46 条
[1]   Does the MTHFR 677T allele alter the clinical phenotype in severe haemophilia A? [J].
Ahmed, R ;
Kannan, M ;
Choudhry, VP ;
Saxena, R .
THROMBOSIS RESEARCH, 2003, 109 (01) :71-72
[2]   A LONGITUDINAL-STUDY OF ORTHOPEDIC OUTCOMES FOR SEVERE FACTOR-VIII-DEFICIENT HEMOPHILIACS [J].
ALEDORT, LM ;
HASCHMEYER, RH ;
PETTERSSON, H ;
EIBL, H ;
GILBERT, M ;
HILGARTNER, M ;
KUNSHACK, M ;
LARRIEU, MJ ;
LEVINE, P .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (04) :391-399
[3]  
ARBINI AA, 1995, THROMB HAEMOSTASIS, V74, P1255
[4]   Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized [J].
Astermark, J ;
Petrini, P ;
Tengborn, L ;
Schulman, S ;
Ljung, R ;
Berntorp, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) :1109-1113
[5]   The thrombophilias: Well-defined risk factors with uncertain therapeutic implications [J].
Bauer, KA .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) :367-373
[6]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[7]   von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis [J].
Blann, AD ;
McCollum, CN .
BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (06) :375-380
[8]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[9]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[10]   PHYSIOLOGICAL ANTICOAGULATION - RESISTANCE TO ACTIVATED PROTEIN-C AND VENOUS THROMBOEMBOLISM [J].
DAHLBACK, B .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) :923-927